← Eichor
Study identifier: NCT02916810 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Alternative Stimulation Mode and Location for Auditory Hallucination Neuromodulation Treatment

Condition: Schizophrenia and Related Disorders  ·  Sponsor: The University of Texas Health Science Center, Houston

PhaseNA
Planned participants140
Who can joinAll sexes, 18 Years to 50 Years
Healthy volunteersNo

About this study

The purpose of the study is to test the hypothesis that functionally navigated repetitive TMS stimulations to the prefrontal cortex (PFC) modulate aberrant cortical electrical activities at PFC circuitry. The TMS location of the PFC site will be individually localized by the symptom-related functional connectivity between PFC and symptom related areas (such as the auditory and language processing cortex). The investigators predict that such modulation will correct abnormal activities in patients with schizophrenia, reduce symptoms, especially auditory hallucination, and improve working memory/sustained attention performance.

This description comes directly from the study's public registry record.

Talk to the study team

Xiaoming Du, PhD  ·  (713) 486-2700  ·  Xiaoming.Du@uth.tmc.edu

Always discuss trial participation with your own doctor first.

Locations (1)

The University of Texas Health Science Center at HoustonHouston, Texas, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT02916810